Intestinal barrier homeostasis in inflammatory bowel disease

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 1, 2014, Pages 3-12

  Goll, Rasmus ^a   Van Beelen Granlund, Atle ^b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Homeostasis; Inflammatory bowel disease; Intestinal epithelial barrier

Indexed keywords

BIOLOGICAL MARKER;

ENTEROENDOCRINE CELL; HOMEOSTASIS; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; METABOLISM; MUCUS; PHYSIOLOGY;

BIOLOGICAL MARKERS; ENTEROENDOCRINE CELLS; HOMEOSTASIS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MUCUS;

EID: 84919458294     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.971425     Document Type: Review

References (106)

1. Mondot S, de Wouters T, Doré J, Lepage P. The human gut microbiome and its dysfunctions. Dig Dis 2013;31:278-85.
2. Johansson ME V, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 2008;105:15064-9.
3. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev 2011;241:241-59.
4. Brandtzaeg P, Carlsen HS, Halstensen TS. The B-cell system in inflammatory bowel disease. In Blumberg RS, Neurath MF, editors. Immune mechanisms in inflammatory bowel disease. Springer, New York; 2000. pp 19.
5. Barker N, van Es JH, Kuipers J, van den Born M, Cozijnsen M, Haegebarth A, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-7.
6. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009;459:262-5.
7. Clevers H. Stem Cells: A unifying theory for the crypt. Nature 2013;495:53-4.
8. Walther V, Graham TA. Location, location, location! The reality of life for an intestinal stem cell in the crypt. J Pathol 2014;234:1-4.
9. Tian H, Biehs B, Warming S, Leong KG, Rangell L, Klein OD, et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 2012;482:120-0.
10. Metcalfe C, Kljavin NM, Ybarra R, De Sauvage FJ. Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell 2014;14:149-59.
11. Leblond CP, Walker BE. Renewal of cell populations. Physiol Rev 1956;36:255-76.
12. Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol 2014;15:19-33.
13. Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 2003;17:1709-13.
14. Fevr T, Robine S, Louvard D, Huelsken J. Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol 2007;27:7551-9.
15. Peeters T, Vantrappen G. The Paneth cell: a source of intestinal lysozyme. Gut 1975;16:553-8.
16. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjöberg J, Amir E, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010;11:76-83.
17. Tanaka M, Saito H, Kusumi T, Fukuda S, Shimoyama T, Sasaki Y, et al. Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease. J Gastroenterol Hepatol 2001;16:1353-9.
18. Simmonds N, Furman M, Karanika E, Phillips A, Bates AWH. Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children. BMC Gastroenterol 2014;14:93.
19. Van Beelen Granlund A, Østvik AE, Brenna Ø, Torp SH, Gustafsson BI, Sandvik AK. REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation. Cell Tissue Res 2013;352:639-46.
20. Gregorieff A, Pinto D, Begthel H, Destrée O, Kielman M, Clevers H. Expression Pattern of Wnt Signaling Components in the Adult Intestine. Gastroenterology 2005;129:626-38.
21. Poulsen SS, Nexø E, Olsen PS, Hess J, Kirkegaard P. Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry 1986;85:389-94.
22. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van de Born M, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011;469: 415-18.
23. Ireland H, Houghton C, Howard L, Winton DJ. Cellular inheritance of a Cre-activated reporter gene to determine Paneth cell longevity in the murine small intestine. Dev Dyn 2005;233:1332-6.
24. Buczacki SJ a, Zecchini HI, Nicholson AM, et al. Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature 2013; 495: 65-9.
25. Roth S, Franken P, Sacchetti A, Kremer A, Anderson K, Sansom O, et al. Paneth cells in intestinal homeostasis and tissue injury. PLoS One 2012;7.
26. Bruno MEC, Frantz a L, Rogier EW, Johansen F-E, Kaetzel CS. Regulation of the polymeric immunoglobulin receptor by the classical and alternative NF-kB pathways in intestinal epithelial cells. Mucosal Immunol 2011;4:468-78.
27. Brittan M, Wright NA. Gastrointestinal stem cells. J Pathol 2002;197:492-509.
28. Madara JL. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J Membr Biol 1990;116: 177-84.
29. Vereecke L, Beyaert R, van Loo G. Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol Med 2011;17:584-93.
30. Thibault R, Blachier F, Darcy-Vrillon B, de Coppet P, Bourreille A, Segain J-P. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflamm Bowel Dis 2010;16:684-95.
31. Bordin M, D'Atri F, Guillemot L, Citi S. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res 2004;2:692-701.
32. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, et al. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 1999;112:137-46.
33. Buschmann MM, Shen L, Rajapakse H, Raleigh DR, Wang Y, Wang Y, et al. Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux. Mol Biol Cell 2013; 24:3056-68.
34. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 1999;116:301-9.
35. He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009;137:1100-11.
36. Piguet PF, Vesin C, Guo J, Donati Y, Barazzone C. TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53. Eur J Immunol 1998;28: 3499-505.
37. Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Küchler AM. Interleukin-33-cytokine of dual function or novel alarmin? Trends Immunol 2009;30:227-33.
38. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479-90.
39. Gribar SC, Richardson WM, Sodhi CP, Hackam DJ. No Longer an Innocent Bystander: Epithelial Toll-Like Receptor Signaling in the Development of Mucosal Inflammation. Mol Med 2008;14:645-59.
40. Miron N, Cristea V. Enterocytes: Active cells in tolerance to food and microbial antigens in the gut. Clin Exp Immunol 2012;167:405-12.
41. Lee J, Mo J-H, Katakura K, Alkalay I, Rucker AN, Liu YT, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006;8:1327-36.
42. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002;295:1726-9.
43. Van der Sluis M, De Koning BAE, De Bruijn ACJM, Velcich A, Meijerink JP, Van Goudoever JB, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006;131:117-29.
44. Grootjans J, Hundscheid IH, Buurman WA. Goblet cell compound exocytosis in the defense against bacterial invasion in the colon exposed to ischemia-reperfusion. Gut Microbes 2013;4:232-5.
45. Gunawardene AR, Corfe BM, Staton CA. Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol 2011;92:219-31.
46. Blalock JE. The immune system as the sixth sense. J Intern Med 2005;257:126-38.
47. Gonzalez-Rey E, Chorny A, Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol 2007;7:52-63.
48. Ashizuka S, Inatsu H, Inagaki-Ohara K, Kita T, Kitamura K. Adrenomedullin as a potential therapeutic agent for inflammatory bowel disease. Curr Protein Pept Sci 2013;14:246-55.
49. Ashizuka S, Kita T, Inatsu H, Kitamura K. Adrenomedullin: A novel therapy for intractable ulcerative colitis. Inflamm Bowel Dis 2013;19:E26-7.
50. Barnes NM, Sharp T. Areview ofcentral 5-HT receptors and their function. Neuropharmacology 1999;38:1083-152.
51. Young MR, Matthews JP. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology 1995;84:148-52.
52. Ghia J-E, Li N, Wang H, Collins M, Deng Y, El-Sharkawy RT, et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 2009;137:1649-60.
53. Johansson ME V, Gustafsson JK, Holmén-Larsson J, Jabbar KS, Xia L, Xu H, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 2014;63:281-91.
54. Andrianifahanana M, Moniaux N, Batra SK. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta 2006;1765:189-222.
55. Corfield AP. Mucins: a biologically relevant glycan barrier in mucosal protection. Biochim Biophys Acta 2014. doi: 10.1016/j.bbagen.2014.05.003.
56. Larsson JMH, Karlsson H, Sjövall H, Hansson GC. A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. Glycobiology 2009;19:756-66.
57. Etzold S, Juge N. Structural insights into bacterial recognition of intestinal mucins. Curr Opin Struct Biol 2014;28C: 23-31.
58. Walz A, Odenbreit S, Stühler K, Wattenberg A, Meyer HE, Mahdavi J, et al. Identificationofglycoprotein receptors within the human salivary proteome for the lectin-like BabA and SabA adhesins of Helicobacter pylori by fluorescence-based 2-D bacterial overlay. Proteomics 2009;9:1582-92.
59. Thim L, Madsen F, Poulsen SS. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest 2002;32:519-27.
60. McGuckin MA, Lindén SK, Sutton P, Florin TH. Mucin dynamics and enteric pathogens. Nat Rev Microbiol 2011;9: 265-78.
61. Enss ML, Schmidt-Wittig U, Müller H, Mai UE, Coenen M, Hedrich HJ. Response of germfree rat colonic mucous cells to peroral endotoxin application. Eur J Cell Biol 1996;71:99-104.
62. Glover LE, Colgan SP. Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis. Gastro-enterology 2011;140:1748-55.
63. Pullan RD, Thomas GA, Rhodes M, Newcombe RG, Williams GT, Allen A, et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 1994;35:353-9.
64. Gersemann M, Becker S, Kübler I, Koslowski M, Wang G, Herrlinger KR, et al. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation 2009;77:84-94.
65. McElroy SJ, Prince LS, Weitkamp J-H, Reese J, Slaughter JC, Polk DB. Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2011;301:G656-66.
66. Iwashita J, Sato Y, Sugaya H, Takahashi N, Sasaki H, Abe T. mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells. Immunol Cell Biol 2003;81: 275-82.
67. Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin Microbiol Rev 2006;19:491-511.
68. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci USA 2011;108:4607-14.
69. Larsson E, Tremaroli V, Lee YS, Koren O, Nookaew I, Fricker A, et al. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut 2012;61:1124-31.
70. Frantz AL, Rogier EW, Weber CR, Shen L, Cohen DA, Fenton LA, et al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immuno-globulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol 2012;5:501-12.
71. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 2005;102:18129-34.
72. Chorny A, Puga I, Cerutti A. Regulation of frontline antibody responses by innate immune signals. Immunol Res 2012;54:4-13.
73. Brandtzaeg P. The changing immunological paradigm in coeliac disease. Immunol Lett 2006;105:127-39.
74. Xu L, Teng X, Guo J, Sun M. Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. Inflammation 2012;35: 308-15.
75. Buda A, Jepson MA, Pignatelli M. Regulatory function of trefoil peptides (TFF) on intestinal cell junctional complexes. Cell Commun Adhes 2012;19:63-8.
76. Aamann L, Vestergaard EM, Grønbæk H. Trefoil factors in inflammatory bowel disease. World J Gastroenterol 2014;20: 3223-30.
77. Mahmood A, Melley L, Fitzgerald AJ, Ghosh S, Playford RJ. Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis. Aliment Pharmacol Ther 2005; 21:1357-64.
78. Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev 2014;94: 329-54.
79. Conner EM, Brand SJ, Davis JM, Kang DY, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. Inflamm Bowel Dis 1996;2:133-47.
80. Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, et al. Serial review: reactive oxygen and nitrogen in inflammation guest editor: giuseppe poli role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 2002;33:311-22.
81. Hengstermann S, Valentini L, Schaper L, Buning C, Koernicke T, Maritschnegg M, et al. Altered status of anti-oxidant vitamins and fatty acids in patients with inactive inflammatory bowel disease. Clin Nutr 2008;27:571-8.
82. Shiratora Y, Aoki S, Takada H, Kiriyama H, Ohto K, Hai K, et al. Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 1989;44:163-71.
83. Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, Bulkley GB. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? Pharmacol Ther 1992;53: 375-408.
84. Pastorelli L, De Salvo C, Mercado JR, Vecchi M, Pizarro TT. Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation: Lessons Learned from Animal Models and Human Genetics. Front Immunol 2013;4:280.
85. Mankertz J, Schulzke J-D. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 2007;23:379-83.
86. Granlund A van B, Flatberg A, Østvik AE, Drozdov I, Gustafsson BI, Kidd M, et al. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrateslackofmajordifferencesbetweencrohn'sdisease and ulcerative colitis. PLoS One 2013;8. e56818.
87. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986;105: 883-5.
88. Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 2013;70:631-59.
89. Ye D, Ma I, Ma TY. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2006;290:G496-504.
90. Watson AJM, Hughes KR. TNF-induced intestinal epithelial cell shedding: Implications for intestinal barrier function. Ann N Y Acad Sci 2012;1258:1-8.
91. Kiesslich R, Goetz M, Angus EM, Hu Q, Guan Y, Potten C, et al. Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. Gastroenterology 2007;133:1769-78.
92. Lim LG, Neumann J, Hansen T, Goetz M, Hoffman A, Neurath MF, et al. Confocal endomicroscopy identifies loss of local barrier function in the duodenum of patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2014;20:892-900.
93. Kidd M, Gustafsson BI, Drozdov I, Modlin IM. IL1beta-and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil 2009;21:439-50.
94. Levin AD, van den Brink GR. Selective inhibition of mucosal serotonin as treatment for IBD? Gut 2014;63:866-7.
95. Margolis KG, Stevanovic K, Li Z, Yang QM, Oravecz T, Zambrowicz B, et al. Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut 2014;63:928-37.
96. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13:701-12.
97. Bernstein CN, Walker JR, Graff LA. On studying the connection between stress and IBD. Am J Gastroenterol 2006; 101:782-5.
98. Arijs I, De Hertogh G, Lemaire K, Quintens R, Van Lommel L, Van Steen K, et al. Mucosal gene expression ofantimicrobialpeptidesininflammatory boweldisease before and after first infliximab treatment. PLoS One 2009;4. e7984.
99. Otte J-M, Vordenbäumen S. Role of Antimicrobial Peptides in Inflammatory Bowel Disease. Polymers (Basel) 2011;3: 2010-17.
100. Ho S, Pothoulakis C, Koon HW. Antimicrobial peptides and colitis. Curr Pharm Des 2013;19:40-7.
101. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, et al. Crohn's disease and the NOD2 gene: A role for paneth cells. Gastroenterology 2003;125:47-57.
102. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schäffeler E, Schlee M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004;53:1658-64.
103. Simms LA, Doecke JD, Walsh MD, Huang N, Fowler E V, Radford-Smith GL. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008;57:903-10.
104. Shanahan MT, Carroll IM, Grossniklaus E, White A, von Furstenberg RJ, Barner R, et al. Mouse Paneth cell antimicrobial function is independent of Nod2. Gut 2014; 63:903-10.
105. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, et al. A key role for autophagy and the autop-hagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008;456:259-63.
106. Wehkamp J, Stange EF. Paneth's disease. J Crohn's Colitis 2010;4:523-31.